This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hogan, M. Search for Related Content PubMed Articles by Hogan, M. Social Bookmarking                         What's this?

Oral Midazolam for Pediatric Nonacute Sexual Abuse Examinations

Hennepin County Medical Center

We evaluated oral midazolam as a conscious sedative for children requiring sexual abuse examinations. Thirty-five of 338 children (mean age 49.4 months) received 0.5 mg/kg of midazolam. Midazolam produced adequate sedation in 31 children. Vital signs and oxygen saturation did not vary from baseline during or after the procedure. Oral midazolam appears to be safe and effective for pediatric sexual abuse examinations.

Child Maltreatment, Vol. 1, No. 4, 361-363 (1996)
DOI: 10.1177/1077559596001004008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Atabaki and J. E. Paradise The Medical Evaluation of the Sexually Abused Child: Lessons From a Decade of Research Pediatrics, July 1, 1999; 104(1): 178 - 178. [Full Text]